<SEC-DOCUMENT>0001654954-25-010510.txt : 20250909
<SEC-HEADER>0001654954-25-010510.hdr.sgml : 20250909
<ACCEPTANCE-DATETIME>20250909080208
ACCESSION NUMBER:		0001654954-25-010510
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250903
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250909
DATE AS OF CHANGE:		20250909

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TENAX THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0000034956
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				262593535
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34600
		FILM NUMBER:		251301705

	BUSINESS ADDRESS:	
		STREET 1:		101 GLEN LENNOX DRIVE
		STREET 2:		SUITE 300
		CITY:			CHAPEL HILL
		STATE:			NC
		ZIP:			27517
		BUSINESS PHONE:		919-855-2100

	MAIL ADDRESS:	
		STREET 1:		101 GLEN LENNOX DRIVE
		STREET 2:		SUITE 300
		CITY:			CHAPEL HILL
		STATE:			NC
		ZIP:			27517

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OXYGEN BIOTHERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20080703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SYNTHETIC BLOOD INTERNATIONAL INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SINEQUANON CORP
		DATE OF NAME CHANGE:	19901219
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tennx_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:tennx="http://tenaxthera.com/20250903"><head><title>tennx_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2025-09-03to2025-09-03" id="ixv-278">0000034956</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2025-09-03to2025-09-03" format="ixt:booleanfalse" id="ixv-279">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tennx-20250903.xsd"/></ix:references><ix:resources><xbrli:context id="From2025-09-03to2025-09-03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000034956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-03</xbrli:startDate><xbrli:endDate>2025-09-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="From2025-09-03to2025-09-03" id="ixv-299">8-K</ix:nonNumeric></span></strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2025-09-03to2025-09-03" format="ixt:datemonthdayyearen" id="ixv-300">September 3, 2025</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2025-09-03to2025-09-03" id="ixv-301">Tenax Therapeutics, Inc.</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="From2025-09-03to2025-09-03" format="ixt-sec:stateprovnameen" id="ixv-302">Delaware</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityFileNumber" contextRef="From2025-09-03to2025-09-03" id="ixv-303">001-34600</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="From2025-09-03to2025-09-03" id="ixv-304">26-2593535</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(State or other jurisdiction</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">of incorporation)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Commission</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">File Number)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(IRS Employer</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Identification No.)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="From2025-09-03to2025-09-03" id="ixv-305">101 Glen Lennox Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="From2025-09-03to2025-09-03" id="ixv-306">Suite 300</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="From2025-09-03to2025-09-03" id="ixv-307">Chapel Hill</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="From2025-09-03to2025-09-03" id="ixv-308">NC</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="From2025-09-03to2025-09-03" id="ixv-309">27517</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Address of principal executive offices) (Zip Code)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:CityAreaCode" contextRef="From2025-09-03to2025-09-03" id="ixv-310">919</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="From2025-09-03to2025-09-03" id="ixv-311">855-2100</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Registrant&#8217;s telephone number, including area code)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="From2025-09-03to2025-09-03" format="ixt-sec:boolballotbox" id="ixv-312">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="From2025-09-03to2025-09-03" format="ixt-sec:boolballotbox" id="ixv-313">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="From2025-09-03to2025-09-03" format="ixt-sec:boolballotbox" id="ixv-314">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="From2025-09-03to2025-09-03" format="ixt-sec:boolballotbox" id="ixv-315">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-right:#000000 1px solid;border-bottom:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:35%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Title of each class</p></td><td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Trading Symbol(s)</p></td><td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:35%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Name of each exchange on which registered</p></td></tr><tr style="height:15px"><td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="From2025-09-03to2025-09-03" id="ixv-316">Common Stock, $0.0001 par value per share</ix:nonNumeric></p></td><td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="From2025-09-03to2025-09-03" id="ixv-317">TENX</ix:nonNumeric></p></td><td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric name="dei:SecurityExchangeName" contextRef="From2025-09-03to2025-09-03" format="ixt-sec:exchnameen" id="ixv-318">Nasdaq</ix:nonNumeric> Stock Market LLC</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2025-09-03to2025-09-03" format="ixt-sec:boolballotbox" id="ixv-319">&#9744;</ix:nonNumeric>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 1.01 Entry into a Material Definitive Agreement.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">On September 3, 2025, Tenax Therapeutics, Inc. (the &#8220;Company&#8221;) and Orion Corporation (&#8220;Orion&#8221;) entered into an amendment (the &#8220;Amendment&#8221;) to that certain License Agreement between the Company and Orion dated as of September 20, 2013, as previously amended on October 9, 2020, January 25, 2022, February 19, 2024, and October 2, 2024 (the &#8220;Agreement&#8221;). Under the Amendment, the Company&#8217;s licenses from Orion have been expanded to include exclusive worldwide rights to develop, commercialize, manufacture, and have manufactured any orally-administered pharmaceutical product containing levosimendan and, in addition to the Company&#8217;s existing rights to develop or commercialize subcutaneously administered products containing levosimendan, to manufacture or have manufactured such products. The Amendment also calls for Orion to supply the Company with levosimendan to the extent reasonably necessary or useful to manufacture orally-administered products containing levosimendan for purposes of developing such products, and sets forth the terms for such supply, including the price of levosimendan ordered by the Company of low triple-digit thousands in Euros per kilogram, payment terms, and active pharmaceutical ingredient specifications. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The foregoing summary of the material terms of the Amendment is subject to the full and complete terms of the Amendment, a copy of which is attached to this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein by reference.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 9.01</strong> <strong>Financial Statements and Exhibits.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(d) Exhibits</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exhibit No.</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Description</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="tennx_ex101.htm">10.1*</a></p></td><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="tennx_ex101.htm">Amendment to the License Agreement of September 20, 2013 by and between Tenax Therapeutics, Inc. and Orion Corporation, dated as of September 3, 2025.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">104</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">*Portions of this Exhibit have been omitted pursuant to Items 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish supplementally an unredacted copy of this Exhibit to the Securities and Exchange Commission upon request.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Date: September 9, 2025</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Tenax Therapeutics, Inc.</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:3%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:12%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">By: </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">/s/ Christopher T. Giordano</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Christopher T. Giordano</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">President and Chief Executive Officer</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tennx_ex101.htm
<DESCRIPTION>AMENDMENT TO THE LICENSE AGREEMENT
<TEXT>
<html><head><title>tennx_ex101.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.2pt; text-align:center;"><strong>CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH EXCLUDED INFORMATION HAS BEEN MARKED WITH &#8220;[***].&#8221;</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.2pt; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.8pt; text-align:center;"><font style="font-size:18pt"><strong>FIFTH AMENDMENT </strong>&nbsp;</font></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.8pt; text-align:center;"><font style="font-size:18pt"><strong>TO THE LICENSE AGREEMENT OF SEPTEMBER 20, 2013 </strong>&nbsp;</font></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.45pt; text-align:justify;">This Fifth Amendment to the License Agreement of September 20, 2013 (hereinafter referred to as the &#8220;<u>Amendment</u>&#8221;) is made and executed as of this 3rd day of September, 2025 (&#8220;<u>Effective Date of Amendment</u>&#8221;) by and between:&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.45pt; text-align:justify;"><strong>Orion Corporation</strong>, Business Identity Code 1999212-6, a company registered under the laws of Finland and having its principal office at Orionintie 1, 02200 Espoo, Finland (hereinafter referred to as &#8220;<u>Orion</u>&#8221;); and&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:justify;"><strong>Tenax Therapeutics, Inc.</strong>, a company incorporated under the laws of the State of Delaware, and having its principal office at 101 Glen Lennox Drive, Suite 300, Chapel Hill, NC 27517, USA (hereinafter referred to as &#8220;<u>Licensee</u>&#8221;).&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.45pt; text-align:justify;">Orion and Licensee are collectively referred to herein as the &#8220;<u>Parties</u>&#8221; and each individually as a &#8220;<u>Party</u>&#8221;.&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="2" style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">WHEREAS,&nbsp;&nbsp;this Amendment pertains to that certain agreement entitled &#8220;License Agreement&#8221; between </p></td></tr> <tr style="height:15px"> <td style="width:12%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the Parties, dated September 20, 2013, as amended October 9, 2020 (such amendment, the &#8220;<u>First Amendment</u>&#8221;), January 25, 2022 (such amendment, the &#8220;<u>Second Amendment</u>&#8221;), February 19, 2024 (such amendment, the &#8220;<u>Third</u><u> Amendment</u>&#8221;), and October 2, 2024 (such amendment, the &#8220;<u>Fourth Amendment</u>&#8221;), and subject to that certain letter executed by the Parties August 6, 2024 (the &#8220;<u>Side Letter</u>&#8221;; the License Agreement, as amended by the First Amendment, Second Amendment, Third Amendment, and Fourth Amendment, and subject to the Side Letter, hereinafter, the &#8220;<u>Agreement</u>&#8221;); and&nbsp;&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">WHEREAS, </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;">the Parties now wish, for mutual convenience, to amend the Agreement by, inter alia, clarifying the definition of Modified Oral Product and granting manufacturing rights to Licensee with respect to the Modified Oral Products and the Subcutaneously Administered Product.&nbsp;&nbsp;&nbsp;&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.45pt; text-align:justify;">NOW, THEREFORE, the Parties, in consideration of the premises and of the mutual agreement, covenants and conditions hereinafter set forth, hereby agree and convene as follows:&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1 TERMS USED IN THIS AMENDMENT </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1.1 Unless otherwise explicitly agreed herein, all capitalized terms used herein shall have the same meaning as given to them under the Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1(7)</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>2 AMENDMENTS TO THE AGREEMENT </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.1 The definition of &#8220;Initial Product&#8221; shall be established and added to the Agreement, and shall read as follows:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&#8220;<u>Initial Product</u>&#8221; means the pharmaceutical product containing Levosimendan as an active pharmaceutical ingredient and intended for human use or administration in a hospital or critical care setting (i.e., 2.5 mg/ml concentrate for solution for infusion/ 5ml vial).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.2 The definition of &#8220;Modified Oral Product&#8221; of the Agreement, established by the First Amendment, shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&#8220;<u>Modified Oral Product</u>&#8221; means any orally-administered pharmaceutical product, other than the Oral Product, containing Levosimendan as an active pharmaceutical ingredient (alone or in combination with any other active pharmaceutical ingredient(s)).&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0in; text-align:justify;">2.3 Section 1.39. (&#8220;Product Trademark&#8221;) of the Agreement shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">1.39. &#8220;<u>Product Trademark</u>&#8221; means (i) solely with respect to the Oral Product, the Modified Oral Product and the Subcutaneously Administered Product, any trademark other than Simdax&#174; selected by Licensee, to be registered and owned by Licensee (or its Affiliate or sublicensee) to be used for the Oral Product, the Modified Oral Product or the Subcutaneously Administered Product (as applicable) in the Territory or (ii) with respect to the Initial Product, Simdax&#174; or any other trademark selected by the Parties, registered or registerable and owned by Orion to be used for such Initial Product in the Territory.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.4 Section 2.1. (<u>Development and Commercialization Licenses</u>) of the Agreement shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">2.1. <u>Development and Commercialization Licenses</u>. Subject to the terms and conditions of this Agreement, Orion hereby grants to Licensee under the Orion Patent Rights and Orion Proprietary Information during the Term (and thereafter, subject to the terms and conditions of this Agreement):</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:8%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(a)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">an exclusive right and license, with the right to grant sublicenses subject to Section 2.2, to conduct Development in support of obtaining Regulatory Approval for the Product in the Field in the Territory;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">an exclusive right and license, with the right to grant sublicenses subject to Section 2.2, to Commercialize the Product in the Field in the Territory;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(c) </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">an exclusive right and license, with the right to grant sublicenses subject to Section 2.2, to manufacture or have manufactured Modified Oral Products and the Subcutaneously Administered Product (or Levosimendan for the manufacture of either of the foregoing) for purposes of exercising the rights in clauses (a) and (b) above; and </p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(d)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">an exclusive right and license, with the right to grant sublicenses subject to Section 2.2, to import Products for purposes of exercising the rights above.</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2(7)</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.5 Section 2.3. (<u>License to the Product Trademark</u>) of the Agreement shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">2.3. <u>License to the Product Trademark</u>. The Product shall be Commercialized in the Territory under the Product Trademark. Subject to and in accordance with the terms and conditions of this Agreement, during the Term, Orion hereby grants to Licensee an exclusive license, with the right to sublicense subject to Section 2.2, to use and display the Product Trademark in the Territory solely in connection with the performance by Licensee of its Development and Commercialization obligations with respect to the Initial Product in the Territory. Licensee acknowledges that nothing in this Agreement shall give it any right, title or interest in or to the Product Trademark for the Initial Product other than the limited license granted herein for the duration of the Term. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0in; text-align:justify;">2.6 Section 2.4. (<u>Retention of Rights</u>) of the Agreement shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">2.4. <u>Retention of Rights</u>. All rights not specifically granted to Licensee under this Agreement are expressly reserved and retained by Orion. Without limiting the generality of any of the foregoing, it is expressly understood and agreed that (i) Orion retains all rights under the Orion Patent Rights and Orion Proprietary Information outside the Territory; and (ii) except as set forth in clause (c) of Section 2.1, the grant of rights to Licensee under this Agreement excludes any rights whatsoever for Licensee to manufacture or have manufactured the Product. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.7 Section 7.6. (Grant Back of Licensee&#8217;s IPR) of the Agreement shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">The Parties acknowledges that as a result of this Agreement, Licensee may generate or have generated clinical trial data relating to the Product (&#8220;<u>Licensee Clinical Data</u>&#8221;) and (ii) be issued patents covering inventions conceived and reduced to practice by Licensee related to the Product during the course of this Agreement (&#8220;<u>Licensee Grant-Back Patents</u>&#8221;).&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Without prejudice to and subject to Orion&#8217;s rights to the Licensee Grant-Back Patents outside the Territory (as applicable), as set forth in Section 10.2.1., Licensee hereby grants to Orion an irrevocable, perpetual, transferable sublicensable, fully-paid-up, non-exclusive, royalty-free right and license under the Licensee Clinical Data and Licensee Grant-Back Patents for any and all purposes not in conflict with the rights granted to Licensee under this Agreement. Licensee agrees to promptly notify Orion of any Licensee Clinical Data generated and Licensee Grant-Back Patents issued and shall make available to Orion all Licensee Clinical Data.&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3(7)</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.8 The following new Section 7.9. (<u>Supply of Levosimendan for the Modified Oral Product)</u> shall be added to the Agreement:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">7.9. <u>Supply of Levosimendan for the Modified Oral Product</u>. Orion shall, promptly following Licensee&#8217;s written order(s) from time to time, supply Licensee or its designee with, to the extent reasonably necessary or useful to manufacture Modified Oral Products for use in the Development thereof, Levosimendan conforming to the specifications set forth on Schedule 7.9. hereto, which shall be manufactured, stored, handled, and shipped in accordance with current FDA standards of Good Manufacturing Practices, and which will have a retest date no earlier than thirty-six (36) months following the shipment thereof to Licensee or its designee. The minimum order amount of such Levosimendan shall be [***] grams. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Licensee shall pay Orion a price of [***] Euros (&#8364;[***]) per kilogram of such Levosimendan ordered by Licensee and delivered by Orion, with such payment to be made within forty-five (45) days of Licensee&#8217;s receipt of an invoice therefor, with such invoice not to be provided prior to delivery of such product. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.9 Section 9.2. (<u>Inclusion of Orion&#8217;s Name on Marketing Materials</u>) of the Agreement shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">9.2. (<u>Inclusion of Orion&#8217;s Name on Marketing Materials</u>). Licensee agrees that, to the extent consistent with and subject to regulatory requirements in the Territory, appropriate language shall be included in the advertising, promotion and marketing materials for the Product identifying the Product as being licensed from and, if supplied to Licensee in finished form by Orion, manufactured by Orion. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.45pt; text-align:justify;">2.10 Section 11.1. (<u>Ownership</u>) of the Agreement shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">11.1. (<u>Ownership</u>). Licensee acknowledges that Orion is the sole and exclusive owner of the Product Trademark with respect to the Initial Product within the Territory. All goodwill resulting from use of such Product Trademark by or on behalf of Licensee shall at all times inure solely to the benefit of Orion. Licensee may not register or cause to be registered such Product Trademark or any mark confusingly similar thereto with any national, state or provincial or other governmental authority. Licensee agrees that it will not at any time dispute or contest (i) the validity of such Product Trademark and/or any registrations thereof, whether now existing or hereafter obtained; (ii) the exclusive ownership by Orion of such Product Trademark and/or of any registrations thereof, whether now existing or hereafter obtained; (iii) the exclusive ownership by Orion of the present and future goodwill pertaining to such Product Trademark; or (iv) Orion&#8217;s right to grant to Licensee the rights conferred by this Agreement as to such Product Trademark. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.11 Section 11.2 (<u>Product Trademark on Materials</u>) of the Agreement shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">11.2.<u> Product Trademark on Materials</u>. It shall be clearly indicated on the Product&#8217;s labels, packaging and inserts, and all sales, marketing and promotional materials that the Product Trademark is a registered trademark using the symbol &#174; or any other appropriate symbol indicating the registration status of the Product Trademark. Orion retains the right to review and approve all intended uses of the Initial Product&#8217;s Product Trademark prior to the first use thereof, such approval not to be unreasonably withheld, conditioned or delayed. It is expressly understood and agreed that Orion&#8217;s review of such materials shall not be deemed a qualification of or otherwise release Licensee of its sole and exclusive responsibility relating to any use of the Product Trademark. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4(7)</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.45pt; text-align:justify;">2.12 Section 11.3. (<u>Domain Names</u>) of the Agreement shall be replaced with the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">11.3. <u>Domain Names</u>. Licensee shall have the right to apply for, acquire and/or register domain </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">names specific to the countries comprised in the Territory that incorporate the Initial Product&#8217;s Product Trademark in Orion&#8217;s name and at Licensee&#8217;s own cost. Any such domain names shall be owned by Orion. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.13 The Agreement shall be amended by adding Schedule 7.9, attached to this Amendment, as Schedule 7.9 of the Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>3 EFFECTIVE DATE </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">3.1 The amendments to the Agreement agreed upon herein shall become effective as of the Effective Date of Amendment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>4 OTHER PROVISIONS </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">4.1 For the avoidance of doubt it is stated that except for what has been stipulated herein above, all other terms and conditions of the Agreement will remain unchanged.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">4.2 The terms and conditions of the Agreement with regard to the choice of law and dispute resolution will apply to this Amendment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:center;"><em>***Balance of page left blank. Signature page follows.*** </em>&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5(7)</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.45pt; text-align:justify;"><strong>IN WITNESS WHEREOF, </strong>the Parties, through their authorized representatives, have executed two (2) identical counterparts of this Amendment.&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.45pt; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Orion Corporation</strong></p></td> <td style="width:14%;"></td> <td style="width:35%;"></td> <td style="width:12%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td></td> <td></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">By: /s/ p.p. Satu Ahom&#228;ki</p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">By: /s/ p.p. Patrik Kass</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td></td> <td></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td>Name: p.p. Satu Ahom&#228;ki </td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Name: p.p. Patrik Kass</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td></td> <td></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Title: EVP </p></td> <td></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Title: Director Generics business</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td></td> <td></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Tenax Therapeutics, Inc. </strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By: /s/ Christopher T. Giordano</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name: Christopher T. Giordano</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Title: President &amp; CEO</p></td> <td></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0in; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6(7)</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.1pt; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.1pt; text-align:center;"><strong>SCHEDULE 7.9. </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.1pt; text-align:center;"><strong>MODIFIED ORAL PRODUCT API SPECIFICATIONS </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:justify;"><strong><u>Specifications, Levosimendan milled</u> </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp;</p> <table style="border-spacing:0;font-size:10pt;border-right:#000000 1px solid;border-bottom:#000000 1px solid;text-align:justify;width:100%" cellpadding="3"> <tr style="height:15px"> <td style="border-top:#000000 1px solid;border-left:#000000 1px solid;padding:3px;width:30%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.2pt; TEXT-INDENT: 0in; text-align:left;"><strong>Test </strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;width:40%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.2pt; TEXT-INDENT: 0in; text-align:left;"><strong>Acceptance criterion </strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;width:30%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.2pt; TEXT-INDENT: 0in; text-align:left;"><strong>Test method </strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>[***]</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:3px;padding-top:3px;padding-left:3px;border-left:#000000 1px solid;padding-right:3px;padding:3px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:left;"><strong>[***]</strong></p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 0in; text-align:justify;"><strong>[***]</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7(7)</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>tennx-20250903.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/08/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:us-types="http://fasb.org/us-types/2025" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:cyd="http://xbrl.sec.gov/cyd-af-sub/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:tennx="http://tenaxthera.com/20250903" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://tenaxthera.com/20250903">
 <annotation>
  <appinfo>
   <link:roleType roleURI="http://tenaxthera.com/role/Cover" id="Cover">
    <link:definition>000001 - Document - Cover</link:definition>
    <link:usedOn>link:presentationLink</link:usedOn>
    <link:usedOn>link:calculationLink</link:usedOn>
    <link:usedOn>link:definitionLink</link:usedOn>
   </link:roleType>
   <link:linkbaseRef xlink:type="simple" xlink:href="tennx-20250903_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="tennx-20250903_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="tennx-20250903_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="tennx-20250903_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
  </appinfo>
 </annotation>
 <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
 <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
 <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
 <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
 <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
 <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
 <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
 <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>tennx-20250903_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/08/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>tennx-20250903_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/08/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://tenaxthera.com/role/Cover" xlink:href="tennx-20250903.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://tenaxthera.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>tennx-20250903_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/08/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://tenaxthera.com/role/Cover" xlink:href="tennx-20250903.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tenaxthera.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>tennx-20250903_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/08/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://tenaxthera.com/role/Cover" xlink:href="tennx-20250903.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tenaxthera.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Tenax Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000034956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  03,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2593535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">101 Glen Lennox Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Chapel Hill<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">27517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">855-2100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TENX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tennx_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tenaxthera.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>tennx-20250903.xsd</File>
    <File>tennx-20250903_cal.xml</File>
    <File>tennx-20250903_def.xml</File>
    <File>tennx-20250903_lab.xml</File>
    <File>tennx-20250903_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tennx_8k.htm">tennx_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tennx_8k.htm": {
   "nsprefix": "tennx",
   "nsuri": "http://tenaxthera.com/20250903",
   "dts": {
    "schema": {
     "local": [
      "tennx-20250903.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "tennx-20250903_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tennx-20250903_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "tennx-20250903_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tennx-20250903_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tennx_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://tenaxthera.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-09-03to2025-09-03",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tennx_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-09-03to2025-09-03",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tennx_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://tenaxthera.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001654954-25-010510-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001654954-25-010510-xbrl.zip
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MM/W/RF6#^?#VZS28"[CY.+(X]3,--_\#4$L#!!0    ( $- *5OO/*X<WP$
M )@#   6    =&5N;G@M,C R-3 Y,#-?8V%L+GAM;(U32X^;,!"^5^I_F-)#
M6ZG&D*C2!H5=Y;&'2-D>DK;:J]<,P:JQ(]L$\N_7)@O=J*VT'!!FOM<,P_RN
MJR6<T%BA51ZE<1(!*JX+H0YYU%C"+!<B NN8*IC4"O/HC#:ZNWW_;OZ!D,?E
M;@MKS9L:E8.50>:P@%:X"D+I@5F'AI 7]*^+3P:3>!HG-^/[);.>I57/\<5T
MK*R]'N@2>%#NJ<F,)C=TDDR^C:"]+EW+# (SO!(.N6L,DU"@%0<%/CA<&LI@
M\8G#NF*F9D>#-5.A*5B<7#QJK?3Q;,2A<O"9?X%@ QOR_?X'+!LK%%H+>RV;
M$,5^A8WB,2RDA%U@6-BA17/"XD5."O4["[<GWQ_X02N;=5;D4>7<,:.T;=NX
MG<;:''P_24H?'[9[7OE<1*@P<([1P HJ_^*EL]F,]M4!^A>R>S)R\)C2(8Z'
M6Y'9WFZK>3_<-]#@OXAP(@.,A%<DG9!I&G>VB/PT "[S,%KB#DN \/!SMQE-
M'2K6N0H-B[FN:2C3E?:KZ:/VS,I@F4<>ICH2/DPR2Z9!_>,5RIV/?D>MJ(_2
M-TE?.7,F>2/[3K?^?(7'SNL66 PJP?WMR9QP 9Y<KA3(GU_BU6-8Q'OEL6>_
M.*7V2QBB7#+.Z=6RW#X#4$L#!!0    ( $- *5L1R/:)EP(  %$(   6
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M2F*.'.SE(]<R'M %^"IR3#TY<T_>N?V3_F\Y:$H78NLQ!![S5U@@7VR8%T*
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M"M1 .[^)$%MBLOS(Z%:L1C1:>\3<U UHFZV]5G"QP6NA+3#&<76&9I]1(.%
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MU":=GR+RD%"5TKF"E IKBG1>377?5U?.UXK-$D-^CGXA=AC2#YY[8W*_T$R
MUF0D^<*&HG\E?1%528=S,K0M-!F"!O4*\;8[SL0_;?LT07\$00O=7FEV5TF,
MF;?#<+E<5I?-JE0S]%.KAY^?'D=1@G$%3%C@$51VK6PO>>WJK58KS,[NI&?*
MU43QW1C-<!<.RC5KZVRX1QEE<!V:D4*%_13L9($]%-0;0;->7>FX@C0(V?!0
MDL,0IL2^_C'L[\<T(.C*)*!H-9)I:$^'78F9B9%F#1,%T[L*RL0JL/-2:]6:
MMO,?CU1F/<<4U2R=<_08'@R,,ZXQ23.GCWC@J &LL.,8XETW=GCWT PS5E[;
M/.HD^'I)!"13D@&= >;+5&+NV0@V2':Q<1D=A</MC,@3ZS8:C>%DW#5$U9E\
M#6-@V<5@WV18,B3XX4LV;F>BC:*1V?7$Z01XUO\7U)Q(PO\\IIY 5.LAS)@=
M4YAGFD)^:/G*XP@/9[2C(B)5# JG8=<C+@='\WB>M%M%.,?50Y@ 5P^^3X&I
MDFD1J2T7>2'<0WPXU/4(=]$-+H%]3.G5)UB7(3Z3.C&N>V-<8.VJD'=7]QA[
MS&=[K'!"VO" -,_(54EV</381O"!TUD^RA.)$\NF!Y:Y5CQ<^[T4U QW.Q^5
M7)JD*],Y%:4K0$$#)]!OO*T#I3:]K 8#4$S&/1';36OYLG B=4+]UN/ZD&O-
M0VY_8!R>%^GDZ]8K+Z$/54YH?_.6Q>>&/%#%,D:JN509EA'2@:Y<X+?LNBOC
MTNW9A89.['_WQM[)MH?I&--5/T:#;,HV==GEC"]LXC0%-]ZFX()5#_ [<8R0
M]/8%ZT2HEX'/E3M!;WF#7F+Q?P&\\6W &ZXEB[^ZL,2C/^)=?/NBQG(I''@?
MBMUH^ZL0"_WY8YU]N[RH@9*O;/.SWB7@9RW<J/LH(EV<^D,_D-I0_C>;7]K,
MY.O=L/NH-R^[O"IT>[EU%-!BS,<*-[ ^ZLL\)U=%:7^/YX-$BM):YUSEAM1'
M'5GDZ*I81Q M%,YMO3$9VQ_L\[&>J]RP^J@ABQQ=%>M847MS;;1.)Y+G,SV1
MN 'U41CF>O&2I+U5E% Q@^([)/E*-[8^*KXR9U=%_!=&84!T99HNQ+;NU/F,
M"Z1ND'U4>*7>KIO(DK.(&;R:GG!'J!@M6!OR=&[W2WS4<\6NK@IWH,!.,> .
M.[M]8^]=JY?IM&BO4*9W@^VCG+OLTB?TOM8+4-^*/J>5VP3XJ.Q<'9]-PVUX
MYN41#]@_Q6S.V"?[1Y%W_P)02P,$%     @ 0T I6V 4\/U_$   L6(   P
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M3K.1+AB/4*@?%V+<7>&-B=)CG\7M%O5Y/ZC]%BG->^.C'O2M.7:HB>9#IDC
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M>YQ)8N;*EBZ8C=:WK$CF.]?35]G10^"2\-(G6$"D/@6KJ4^GE?:;MDVFZ:T
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MWHB#\RP]MGIO-X,S@!YS$[]:BP*([/'$PJ/)7,*1!OR\DAUQ'ZS#EH-<O3&
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M$J@P4#R"SRF5U]A[5+U":]9Q 2X9S> ^6)#&NW?OFHWFSIL:X\P)IB'W9[#
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M?%"!I_(C@S,/VUS\(8=9H-)OY#S-86B23 5X*&A;&,_"9#9&L>^G(@CL8I!
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MOV!4FT<(M0JX5CEK+W5"C5V6:6* J>],P# #J4BX8X-14 .W1SJ3C/KR;@U
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M98S]7,0(*7\B/+>6E3:9+=3@1O*9<(D05DW?%^2:F74BS[,U-72% QKB 2/
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M+GAS9%!+ 0(4 Q0    ( $- *5OO/*X<WP$  )@#   6              "
M 7T$  !T96YN>"TR,#(U,#DP,U]C86PN>&UL4$L! A0#%     @ 0T I6Q'(
M]HF7 @  40@  !8              ( !D 8  '1E;FYX+3(P,C4P.3 S7V1E
M9BYX;6Q02P$"% ,4    " !#0"E;JYFZ !L&  "C.0  %@
M@ %;"0  =&5N;G@M,C R-3 Y,#-?;&%B+GAM;%!+ 0(4 Q0    ( $- *5LG
M8Q5/EP0  ($D   6              "  :H/  !T96YN>"TR,#(U,#DP,U]P
M<F4N>&UL4$L! A0#%     @ 0T I6V 4\/U_$   L6(   P
M ( !=10  '1E;FYX7SAK+FAT;5!+ 0(4 Q0    ( $- *5L.5O'-'A<  $+
M   /              "  1XE  !T96YN>%]E>#$P,2YH=&U02P4&      <
,!P#' 0  :3P

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>tennx_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tennx-20250903.xsd" xlink:type="simple"/>
    <context id="From2025-09-03to2025-09-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000034956</identifier>
        </entity>
        <period>
            <startDate>2025-09-03</startDate>
            <endDate>2025-09-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2025-09-03to2025-09-03" id="ixv-278">0000034956</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2025-09-03to2025-09-03" id="ixv-279">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2025-09-03to2025-09-03" id="ixv-299">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2025-09-03to2025-09-03" id="ixv-300">2025-09-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2025-09-03to2025-09-03" id="ixv-301">Tenax Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-09-03to2025-09-03" id="ixv-302">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2025-09-03to2025-09-03" id="ixv-303">001-34600</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-09-03to2025-09-03" id="ixv-304">26-2593535</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-09-03to2025-09-03" id="ixv-305">101 Glen Lennox Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-09-03to2025-09-03" id="ixv-306">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-09-03to2025-09-03" id="ixv-307">Chapel Hill</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-09-03to2025-09-03" id="ixv-308">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-09-03to2025-09-03" id="ixv-309">27517</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-09-03to2025-09-03" id="ixv-310">919</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-09-03to2025-09-03" id="ixv-311">855-2100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2025-09-03to2025-09-03" id="ixv-312">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2025-09-03to2025-09-03" id="ixv-313">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2025-09-03to2025-09-03" id="ixv-314">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2025-09-03to2025-09-03" id="ixv-315">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2025-09-03to2025-09-03" id="ixv-316">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2025-09-03to2025-09-03" id="ixv-317">TENX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2025-09-03to2025-09-03" id="ixv-318">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-09-03to2025-09-03" id="ixv-319">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
